Literature DB >> 29804939

Ambulatory hypertension in a pediatric cohort of sickle cell disease.

Divya G Moodalbail1, Bonita Falkner2, Scott W Keith2, Robert S Mathias3, Carlos E Araya3, Joshua J Zaritsky4, Marie J Stuart4.   

Abstract

Hypertension is an established risk factor for subsequent cardiovascular and renal disease in children as well as adults. Sickle cell disease (SCD) is a genetic disorder associated with chronic hemolytic anemia with the major manifestation of vaso-occlusive crises. Although this disease entity involves most organ systems causing vascular and pulmonary injury, little is known about blood pressure (BP) levels or prevalence of hypertension in children with SCD. A cross-sectional study was conducted on 56 children with SCD (54 with hemoglobin SS disease; 2 with hemoglobin Sβ0 thalassemia; 29 females). Study participants underwent 24-hour ambulatory BP monitoring (ABPM). Serum creatinine and cystatin C were obtained to assess estimated glomerular filtration rate with age-based formulas. A random urine sample was obtained to estimate urine osmolality and urine albumin to creatinine ratio. Mean age range was 11.9 (±4.5) years. Seventeen participants (30%) met criteria for hypertension based on ABPM. Of the 17 participants classified with hypertension, three had office hypertension with ambulatory hypertension, and 14 had masked hypertension detected on ABPM. Another 28 participants (50%) had some abnormal ABPM parameters in the form of either prehypertension and/or lack of normal nocturnal dipping status. The prevalence of confirmed hypertension, largely manifest by masked hypertension, is high in children, as young as 6 years of age with SCD. Early identification of hypertension in SCD children can confer benefit as it is an important modifiable risk factor for progression of cardiovascular and renal disease.
Copyright © 2018 American Society of Hypertension. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ambulatory blood pressure monitoring (ABPM); blood pressure (BP); chronic kidney disease (CKD); sickle cell disease (SCD)

Year:  2018        PMID: 29804939     DOI: 10.1016/j.jash.2018.04.005

Source DB:  PubMed          Journal:  J Am Soc Hypertens        ISSN: 1878-7436


  6 in total

1.  Kidney Function Decline among Black Patients with Sickle Cell Trait and Sickle Cell Disease: An Observational Cohort Study.

Authors:  Kabir O Olaniran; Andrew S Allegretti; Sophia H Zhao; Maureen M Achebe; Nwamaka D Eneanya; Ravi I Thadhani; Sagar U Nigwekar; Sahir Kalim
Journal:  J Am Soc Nephrol       Date:  2019-12-06       Impact factor: 10.121

2.  Hyperfiltration during early childhood precedes albuminuria in pediatric sickle cell nephropathy.

Authors:  Jeffrey D Lebensburger; Inmaculada Aban; Brandi Pernell; Malgorzata Kasztan; Daniel I Feig; Lee M Hilliard; David J Askenazi
Journal:  Am J Hematol       Date:  2019-01-08       Impact factor: 10.047

Review 3.  Thrombospondin-1 in maladaptive aging responses: a concept whose time has come.

Authors:  Jeffrey S Isenberg; David D Roberts
Journal:  Am J Physiol Cell Physiol       Date:  2020-05-06       Impact factor: 4.249

4.  Blood pressure unknowns of sickle cell disease in children.

Authors:  Bonita Falkner
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-08-09       Impact factor: 3.738

Review 5.  Sickle cell nephropathy: insights into the pediatric population.

Authors:  Oyindamola C Adebayo; Lambertus P Van den Heuvel; Wasiu A Olowu; Elena N Levtchenko; Veerle Labarque
Journal:  Pediatr Nephrol       Date:  2021-05-29       Impact factor: 3.651

6.  Unmasking hypertension in children and adolescents with sickle/beta-thalassemia.

Authors:  Stella Stabouli; Christina Antza; Eleni Papadopoulou; Aikaterini Teli; Vasilios Kotsis; Marina Economou
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-08-06       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.